Skip to main content

Table 1 Treatment and maternal characteristics of the biopsy and non-biopsy groups

From: Cleavage-stage or blastocyst-stage embryo biopsy has no impact on growth and health in children up to 2 years of age

 

EBD5 FET

N= 222

EBD3 FET

N=322

EBD3 FRESH

N=308

Non-biopsy FET

N=751

Non-biopsy FRESH

N=781

Treatment characteristics

 Number oocytes at retrieval (n, %)

  <4

7 (3.2)

3 (0.9)

10 (3.2)

3 (0.4)

20 (2.6)

  4-18

162 (73.0)

191 (59.3)

254 (82.5)

469 (62.5)

679 (86.9)

  >18

53 (23.9)

128 (39.8)

44 (14.3)

279 (37.2)

82 (10.5)

 Supernumerary embryo(s) for vitrification

  Yes

  

182 (59)

 

654 (84)

  No

  

126 (41)

 

127 (16)

 Type of sperm (n, %)

  Ejaculated sperm

217 (97.7)

316 (98.1)

301 (97.7)

709 (94.4)

726 (93.0)

  Non-ejaculated sperm

5 (2.3)

6 (1.9)

7 (2.3)

42 (5.6)

55 (7.0)

 Origin of sperm (n, %)

  Partner sperm

220 (99.1)

314 (97.5)

303 (98.4)

644 (85.8)

674 (86.3)

  Donor sperm

2 (0.9)

8 (2.5)

5 (1.6)

107 (14.2)

107 (13.7)

 Indication for embryo biopsy (n, %)

  Genetic with infertility

53 (23.9)

18 (5.6)

35 (11.4)

  

  Genetic without infertility

133 (59.9)

302 (93.8)

267 (86.7)

  

  Non-genetic with infertility

36 (16.2)

2 (0.6)

6 (1.9)

  

 Indication for ICSI (n, %)

  Male factor

   

286 (38.1)

299 (38.3)

  Female factor

   

160 (21.3)

142 (18.2)

  Combined male + female factor

   

79 (10.5)

63 (8.1)

  Idiopathic

   

226 (30.1)

277 (35.4)

 Cycle protocol (n, %)

  Hormonal replacement therapy

109 (49.1)

158 (49.0)

0

279 (37.1)

0

    (Modified) Natural cycle

106 (47.6)

154 (47.9)

0

458 (61.0)

5 (0.6)

  Stimulated cycle

7 (3.1)

10 (3.1)

308 (100)

14 (1.9)

776 (99.4)

 Cycle strategy (n, %)

  Freeze-all

222 (100)

228 (70.8)

 

396 (52.7)

 

  Previous embryo transfer

0 (0)

94 (29.2

 

355 (47.3)

 

Maternal characteristics

 Maternal age at delivery, years (mean, SD)

34.2 (4.7)

31.7 (3.6)

31.8 (3.5)

32.9 (3.9)

31.8 (3.9)

 Maternal BMI, kg/m2 (mean, SD)

23.5 (3.6)

23.9 (4.4)

24.3 (4.4)

23.5 (4.5)

23.8 (4.3)

 Pregnancy-induced hypertensive disorder (n, %)

15 (6.8)

27 (8.4)

19 (6.2)

69 (9.2)

50 (6.4)

 Gestational diabetes (n, %)

18 (8.1)

14 (4.3)

22 (7.1)

63 (8.4)

62 (7.9)

 

N=197

N=274

N=252

N=698

N=674

Nulliparous (n, %)

126 (63.9)

160 (58.4)

160 (63.5)

222 (31.9)

156 (23.1)

 

N=198

N=298

N=280

N=613

N=631

Maternal smoking (n, %)

1 (0.5)

6 (2.0)

7 (2.5)

21 (3.4)

27 (4.2)

 

N=202

N=299

N=281

N=660

N=679

Maternal alcohol consumption (n, %)

9 (4.4)

20 (6.7)

20 (7.1)

44 (6.6)

52 (7.6)

  1. EBD5 Embryo Biopsy Day 5, EBD3 Embryo Biopsy Day 3, FRESH fresh embryo transfer, FET frozen-thawed embryo transfer